I now have enough information to give a thorough answer. Let me compile the clinical analysis.
Thalassemia Major Patient - Cardiac Arrest & Death After 3 PCVs: Clinical Analysis
(Note: Assuming "DC" = died/deceased, and defibrillation was used, suggesting VF/VT as the arrest rhythm.)
Most Likely Causes (in order of probability)
1. Transfusion-Associated Hyperkalemic Cardiac Arrest (TAHCA) - TOP SUSPECT
This is the most fitting explanation given the timeline (3 PCVs over 3 days → cardiac arrest → defibrillation attempted → death).
Mechanism:
- Stored packed red blood cells (PRBCs/PCVs) leak potassium into the storage solution over time. Extracellular [K+] in stored RBC units can reach 40-70 mM - far above normal serum levels.
- When multiple units are transfused (especially rapidly or over short days), this potassium load is delivered directly into circulation.
- High K+ shifts the myocardial resting membrane potential, triggering:
- Peaked T waves → widened QRS → VT → ventricular fibrillation → cardiac arrest
- Thalassemia major patients are at extra risk because:
- They are often volume-restricted with low cardiac output (chronic anemia + cardiomyopathy)
- Low cardiac output means poor redistribution of the K+ load from the coronary sinus
- They frequently have pre-existing iron-overload cardiomyopathy, making the heart far more susceptible to arrhythmia
Studies confirm that in one series, a patient developed K+ of 9.0 mEq/L after multiple PRBC units and died from cardiac arrest -
Smith et al., Anesth Analg 2008.
2. Pre-existing Iron Overload Cardiomyopathy
Thalassemia major is a chronic, heavily transfused condition. Each transfusion adds approximately 200-250 mg of iron. Without adequate chelation (deferoxamine, deferasirox), iron deposits in the myocardium cause:
- Dilated cardiomyopathy - reduced EF, poor contractility
- Conduction system damage - susceptibility to lethal arrhythmias
- Restriction/diastolic failure
As confirmed by Goldman-Cecil Medicine: "The main causes of death in adult thalassemia major patients still remain cardiac complications, mainly in poorly chelated patients" and Robbins Pathology: "Cardiac disease resulting from progressive iron overload and secondary hemochromatosis is an important cause of death, particularly in heavily transfused patients."
A patient with established thalassemic cardiomyopathy has a narrow cardiac reserve - any stress (additional iron load, fluid overload, electrolyte disturbance) can tip them into fatal arrhythmia or pump failure.
3. Transfusion-Associated Circulatory Overload (TACO)
3 PCVs in 3 days is a significant volume load. In a thalassemia major patient with:
- Pre-existing cardiac dysfunction (iron-overload cardiomyopathy)
- Possible renal compromise (from iron overload)
The extra fluid can overwhelm the heart's capacity, causing:
- Acute pulmonary edema
- Severe hypertension during transfusion
- Can precipitate acute cardiac arrest
TACO typically presents within 12 hours of transfusion and can be fatal, especially in patients with compromised cardiac function.
4. Acute Hemolytic Transfusion Reaction (AHTR)
If blood group mismatch occurred (ABO or other antibody-mediated), the resulting massive intravascular hemolysis causes:
- Release of cytokines, free hemoglobin
- Disseminated intravascular coagulation (DIC)
- Severe hypotension and shock → cardiac arrest
- This would also explain an acute collapse 3 hours into/after transfusion
Goldman-Cecil also notes: "Adverse reactions to red blood cell transfusions may occur during or after transfusion and can be hemolytic and nonhemolytic."
5. Citrate Toxicity → Hypocalcaemia
- All PCVs are preserved in citrate anticoagulant. Citrate chelates calcium.
- With 3 units in 3 days (especially if given rapidly), citrate accumulation can cause ionized hypocalcaemia.
- Ca2+ is essential for myocardial contraction and conduction.
- Hypocalcaemia → prolonged QT → Torsades de Pointes → VF → cardiac arrest.
- This is worsened if the patient has liver dysfunction (reduced citrate metabolism), which is common in thalassemia major.
Summary Table
| Cause | Mechanism | Why This Patient |
|---|
| Hyperkalemia (TAHCA) | K+ leaches from stored RBCs; VF | 3 PCVs, likely stored blood, low cardiac output state |
| Iron-overload cardiomyopathy | Myocardial iron deposits → arrhythmia | Chronic heavy transfusion history |
| TACO | Volume overload → pulmonary edema | 3 PCVs in 3 days + pre-existing cardiac dysfunction |
| Hemolytic transfusion reaction | ABO mismatch → shock, DIC | If cross-match error occurred |
| Citrate/Hypocalcaemia | Ionized Ca2+ chelated → prolonged QT, VF | Multiple units + liver dysfunction |
Key Preventable Measures (for future cases)
- Use washed/irradiated PRBCs - reduces potassium load significantly
- Transfuse slowly (max 0.5 mL/kg/min in high-risk patients)
- Check electrolytes (K+, Ca2+, Mg2+) before and after each unit
- Adequate iron chelation between transfusion episodes
- Baseline cardiac evaluation (echo, T2* MRI) in all thalassemia major patients
- IV calcium gluconate prophylactically if rapid transfusion is unavoidable
- Diuretics between units if TACO risk is high
The most likely single cause given the clinical picture (VF/VT requiring defibrillation, 3 PCVs, 3 days, thalassemia major with presumed iron burden) is transfusion-induced hyperkalemia (TAHCA) on a background of pre-existing thalassemic cardiomyopathy from iron overload. The two factors together create a perfect storm for fatal arrhythmia.